Navigation Links
Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
Date:6/4/2008

e for us this year. We are extremely pleased to have assembled such a strong group of institutional investors, which is a testament to our accomplished management team and to the trust in our robust oncology pipeline."

The securities sold in the private offering have not been registered under the Securities Act of 1933 and may not be resold absent registration under or exemption from such Act. Arno has agreed to file with the Securities and Exchange Commission a registration statement for the resale of the securities held by the investors in the offering by August 2, 2008. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Arno Therapeutics

Arno Therapeutics is a biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. Arno is initially focusing its efforts on developing its lead compound, AR-67, a novel anti-cancer agent. AR-67 is a third generation campthothecin analogue currently in Phase I clinical trials that has demonstrated high potency and significantly improved pharmacokinetic properties when compared with marketed second-generation products in its class. Arno is also developing AR-12 and AR-42, two novel, preclinical oncology products. A key component of the Company's strategy is to acquire global rights to additional product candidates for the treatment of cancer while continuing to use its technology to develop and commercialize new products and line extensions. For more information on Arno please visit http://www.arnothera.com.

This press release contains statements that are not historical in nature but are forward-looking. These statements are often, but not alwa
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
3. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
4. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
9. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
10. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
11. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... BOHEMIA, N.Y. , July 25, 2014 /PRNewswire-iReach/ -- Dr. ... Pediatrics clinic, GPM Pediatrics, reacts to a recent study, ... adulthood. Photo - http://photos.prnewswire.com/prnh/20140723/129709 ... mothers exposed to severe stress are more likely than others ... occurred months before pregnancy." There were two specific ...
(Date:7/24/2014)... und MARSEILLE , Frankreich, ... , Weltweite Exklusivlizenz der Universität ... die Entwicklung von Tests auf SF3B1-Mutationen, einschließlich ... Neuer Test weist Mutationen des SF3B1-Gens ... Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... 2014  IRIDEX Corporation (NASDAQ: IRIX ) ... 2014 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, July 31, 2014 to ... developments. Interested parties may access the live ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Spirus Medical announced today that it has obtained ... and Welfare for the company,s proprietary ENDO-EASE line of ... "over-tubes" that use a spiral design utilizing simple rotation ... According to Spirus Medical, the Endo-Ease line is well ...
... Companies to Lead Public and Investor Relations Efforts -- BEIJING, Sept. 8 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
Cached Medicine Technology:Spirus Medical Announces Japanese Regulatory Approval to Market ENDO-EASE® Product Line 2Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 2Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 3Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 4Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 5Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 6Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 7Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 8
(Date:7/25/2014)... (PRWEB) July 25, 2014 Health Advocate™, ... and a subsidiary of West Corporation, is introducing its ... Analytics: Reduce Costs and Enhance Quality. , The webinar ... 11 AM ET and again at 2 PM ET. ... please visit http://www.HealthAdvocate.com/Analytics or call 866.799.2655. , ...
(Date:7/25/2014)... Washington, D.C.-- July 25, 2014 -- The Elizabeth ... licensing agreement between the Medicines Patent Pool (MPP) ... tenofovir alafenamide fumarate (TAF), a promising new HIV ... International AIDS Conference (AIDS 2014) in Melbourne, Australia. ... III clinical trials, early data suggests it could ...
(Date:7/25/2014)... 2014 DON’T PAUSE is a popular natural ... hot flashes, mood swings, burning tongue menopause and ... Ershadi. The AntiAging Institute of California is now offering a ... to try this revolutionary product. For a limited time, women ... third bottle at no charge. , Water retention ...
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- Dietary changes can dramatically ... a daily basis, according to a new study. ... might help detect and ease flare-ups for people with ... colitis and Crohn,s disease), the researchers said. Trillions ... effect on human health isn,t well understood, the Massachusetts ...
(Date:7/25/2014)... 2014 The Futon Shop celebrates ... Sale. The Futon Shop has been around since 1976 as ... grown from a few handmade futon mattresses a month, to ... futon mattresses. , The Futon Shop futon mattresses were ... desire to sleep on natural fibers was a growing movement. ...
Breaking Medicine News(10 mins):Health News:Health Advocate™, Inc., Holds Webinar to Introduce Provider-Centered Analytics 2Health News:Health Advocate™, Inc., Holds Webinar to Introduce Provider-Centered Analytics 3Health News:AntiAging Institute of California Now Offers DON'T PAUSE for Menopause with a Special Promotion 2Health News:Diet Changes Can Alter Gut Bacteria, Study Says 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 3
... Vice President of India wants the Government and ... of blood and organ donation. In India., ,Inaugurating ... here, the Vice President asked the government and people to ... donors of blood and organs must be encouraged to save ...
... Researchers have found that physical inactivity due to lack ... surrounding area make rural people obese.// ,The study ... link between obesity and the environmental factors within rural ... of Public Health research that examines the environmental features ...
... dangerous proportions, and now a pill that claims to ... be just what the doctor// ordered. ,This is ... circles. Accomplia, as the pill is called, renders the ... the cravings in their tracks. ,Alarmingly, 23%of ...
... improve the oral health of children and adolescents but ... in an international session of Dental Health. ... Japan, Kuwait, Scotland, Thailand reported in the 84th General ... more work were needed to be done in improving ...
... of Archives of Internal Medicine, which is one of the ... may have more chronic sleep problems than women who do ... women in menopause experience hot flashes, heightened sensations to heat ... hot flashes often occur during the night and have been ...
... they may gain about 20 pounds, according to a new ... 5 pounds// to 15 pounds. ,The findings highlight ... along with smoking cessation programs, say study authors Daniel Eisenberg ... University of California, Berkeley. ,The authors are quick ...
Cached Medicine News:Health News:Environmental Factors Leads to Obesity in Rural Communities 2Health News:Unhealthy Oral Habits among Teenagers – Reported Dental Health Authoritie 2Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Smokers are Prone to Weight Gain After Quitting 2
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
... accurately differentiates clinically significant progression of ... providing an advanced, proven method to ... patients. , ,The software applies knowledge ... in which the actual test/retest variability ...
Medicine Products: